These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 18514481

  • 1. Real life juvenile toxicity case studies: the good, the bad and the ugly.
    De Schaepdrijver L, Rouan MC, Raoof A, Bailey GP, De Zwart L, Monbaliu J, Coogan TP, Lammens L, Coussement W.
    Reprod Toxicol; 2008 Sep; 26(1):54-5. PubMed ID: 18514481
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD, Bailey GP, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Ooshima Y, Stump DG, Hurtt ME.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [Abstract] [Full Text] [Related]

  • 5. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
    Smith D, Combes R, Depelchin O, Jacobsen SD, Hack R, Luft J, Lammens L, von Landenberg F, Phillips B, Pfister R, Rabemampianina Y, Sparrow S, Stark C, Stephan-Gueldner M.
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The value of juvenile animal studies "What have we learned from preclinical juvenile toxicity studies? II".
    Bailey GP, Mariën D.
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):273-91. PubMed ID: 22623019
    [Abstract] [Full Text] [Related]

  • 8. Preclinical evaluation of juvenile toxicity.
    Barrow PC, Barbellion S, Stadler J.
    Methods Mol Biol; 2011 Aug; 691():17-35. PubMed ID: 20972745
    [Abstract] [Full Text] [Related]

  • 9. Improving toxicity screening and drug development by using genetically defined strains.
    Festing MF.
    Methods Mol Biol; 2010 Aug; 602():1-21. PubMed ID: 20012389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Juvenile toxicity: are we asking the right questions?
    Downes N.
    Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
    [Abstract] [Full Text] [Related]

  • 13. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
    Powley MW, Frederick CB, Sistare FD, DeGeorge JJ.
    Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
    [Abstract] [Full Text] [Related]

  • 14. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR, Baetcke K, Blancato J, Bus J, Cohen S, Conolly R, Dixit R, Doe J, Ekelman K, Fenner-Crisp P, Harvey P, Hattis D, Jacobs A, Jacobson-Kram D, Lewandowski T, Liteplo R, Pelkonen O, Rice J, Somers D, Turturro A, West W, Olin S.
    Crit Rev Toxicol; 2007 Feb; 37(9):729-837. PubMed ID: 17957539
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM.
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [Abstract] [Full Text] [Related]

  • 18. Safety evaluation to support First-In-Man investigations I: kinetic and safety pharmacology studies.
    Baldrick P.
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):230-6. PubMed ID: 18501489
    [Abstract] [Full Text] [Related]

  • 19. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
    Moser VC, Walls I, Zoetis T.
    Int J Toxicol; 2005 Jul; 24(2):87-94. PubMed ID: 16036767
    [Abstract] [Full Text] [Related]

  • 20. Embryo-fetal developmental toxicity study design for pharmaceuticals.
    Wise LD, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Lerman SA, Ooshima Y, Stump DG.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):418-28. PubMed ID: 20025038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.